Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?

Bone Marrow Transplant. 2009 Sep;44(5):331-2. doi: 10.1038/bmt.2009.20. Epub 2009 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Dasatinib
  • Female
  • Graft vs Host Disease / etiology*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Thiazoles / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib